BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Fourth Quarter 2025 Results

Progyny (PGNY)ProgynyEarnings

Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full Year Generated Record $210.2 Million in Full Year Operating Cash Flow Returned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent Authorization Issues

Open original release

Related news

PGNYProgyny2026-02-12 19:47 EST

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

TDOCTeladoc2026-02-25 21:05 EST

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

HSTMHealthStream2026-02-23 21:30 EST

HealthStream Announces Fourth Quarter & Full-Year 2025 Results

COOThe Cooper Companies2025-11-04 21:15 EST

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

HSTMHealthStream2026-02-12 14:25 EST

HealthStream to Host Fourth Quarter & Full-Year 2025 Earnings Conference Call

SERASera Prognostics2026-03-18 20:05 EST

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

COOThe Cooper Companies2025-12-04 21:15 EST

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results

SERASera Prognostics2026-03-04 13:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

TDOCTeladoc2026-02-05 21:30 EST

Teladoc Health to Announce Fourth Quarter 2025 Financial Results

View all latest news

Progyny

Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.

Recent company news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Stock data

Close
31.59 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States